Signup/Login
If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
Signup/Login
Can you determine which companies are good and which ones - the trash?
Free Pro-version
IPO Filter
Monitor
IPO today
Upcoming IPO
Priced IPO
Solaredge Technologies, Inc. (SEDG)
The Marygold Companies (MGLD)
Blue Water Vaccines (BWV)
Meihua International Medical Technologies (MHUA)
Smart for Life (SMFL)
Vivakor (VIVK)
TC BioPharm Holdings (TCBP)
Direct Digital Holdings, Llc (DRCT)
Modiv (MDV)
Sky Technologies (SKYX)
Modular Medical (MODD)
HeartCore Enterprises (HTCR)
Arcellx, Inc. (ACLX)
Silver Spike Investment Corp. (SSIC)
Maris-Tech Ltd. (MTEK)
Yoshitsu Co., Ltd. (TKLF)
Tpg Inc. (TPG)
Hillstream BioPharma (HILS)
Hour Loop (HOUR)
Vigil Neuroscience, Inc. (VIGL)
More companies

Blue Water Vaccines (BWV)

Sector - Healthcare

Price chart

N/A
Return from IPO

Company News

IPO Profile

About company

They are a biotechnology company focused on the research and development of transformational vaccines to prevent infectious diseases worldwide. Their versatile vaccine platform has unique molecular properties that enables delivery of various antigens, which can be utilized to develop singular or multi-targeted vaccines. Their lead influenza (flu) vaccine program uses proprietary technology to identify specific epitopes, or proteins, with cross-reactive properties that enables the potential development of a universal flu vaccine. They are focused on developing novel vaccines that induce durable and long-term immunity. They believe that their pipeline and vaccine platform are synergistic for developing next generation preventive vaccines to improve both health outcomes and quality of life globally. Their pipeline includes novel vaccine candidates exclusively licensed from renowned research institutions. They seek to develop vaccines that provide long-lasting immunity to harmful viral and bacterial pathogens that cause infections in patient populations with high unmet needs. Their exclusive license agreements include patented influenza epitopes of limited variability, or ELV, identified through a proprietary computational research and discovery process, discovered by Dr. Sunetra Gupta and her team at the University of Oxford.
Industry
Pharmaceuticals
CEO CFO
-
Employees Founded
9 2018

Contacts

Address: 201 E. Fifth Street, Suite 1900 Cincinnati, Ohio 45202

Telephone: (513) 620-4101

Web page: http://www.bluewatervaccines.com

IPO information

First Trade Date 2/18/2022
Status Priced
Exchange NASDAQ
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range
-
Share prices ($)

Shares & Volumes

Shares Initial (MM) 2.2
Shares Revised (MM) 2.2
Expected offer amount (MM) $24
Realized offer amount(MM) $19.8

Financial Data (last reporting year)

Market Cap (MM) $98.19
Revenues (MM) $0
Net Income (Loss) (MM) $-2.61

Voting

What do you think will happen with the BWV share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes: img
The lead left underwriter: Boustead Securities

IPOs led by the firm .Pro
Profitability of conducted IPOs  ?  .Pro
1st day change  ?  .Pro
Change for the first 3 months  ?  .Pro
Underwriters
Boustead Securities
CO-Managers

Sector: Healthcare

Tweets about $BWV

Tweets volume:

RT volume:

Timeframe:

Google Trends Stats